SCHEMBL4691802

SCHEMBL4691802

NC(=O)c1ccccc1[CH]CCN1CC2CN(C(=O)c3c(Cl)cccc3Cl)C[C@@H]2C1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 14/20 0.48
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
NPC1 O15118 2/20 0.37
HPGD P15428 2/20 0.37
GLA P06280 1/20 0.37
SLC6A1 P30531 2/20 0.34
ACHE P22303 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3284141 0.93 CCR5 (0.42) CCR5HCRTR1HCRTR2SLC6A1MEN1
SCHEMBL4689903 0.92 P2RX7 (0.41) CCR5HPGDSLC6A1MEN1ALDH1A1
SCHEMBL4691301 0.88 HCRTR1 (0.44) CCR5HCRTR1HCRTR2
SCHEMBL4690783 0.87 CCR5 (0.47) CCR5HCRTR1HCRTR2SLC6A1
SCHEMBL4694455 0.85 CHRNB2 (0.44) CCR5HPGDMEN1ALDH1A1KMT2A
SCHEMBL4694264 0.84 ALDH1A1 (0.36) CCR5HCRTR1HCRTR2SLC6A1ACHE
SCHEMBL4694336 0.83 HCRTR1 (0.36) CCR5HCRTR1HCRTR2ALDH1A1
SCHEMBL4691673 0.83 HCRTR1 (0.38) CCR5HCRTR1HCRTR2
SCHEMBL4693059 0.83 CCR5 (0.37) CCR5SLC6A1MEN1ALDH1A1KMT2A
SCHEMBL4690210 0.82 RBP4 (0.35) CCR5HCRTR1HCRTR2SLC6A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed